Sanofi abandoning Auvi-Q after dosage problems led to total recall

in-pharmatechnologist.com

Sanofi is poised to terminate its Auvi-Q marketing deal says PDL Biopharma, citing manufacturing issues last year which led to a complete recall of the epinephrine injection product.